For those ILD cases exposed to methotrexate concomitantly, drug causality assessment can be extremely difficult

Last update : 03/09/2013
I - Interstitial/parenchymal lung disease
III - Pulmonary/alveolar hemorrhage
IV - Airway involvement
V - Pleural and/or pericardial involvement
VI - Pulmonary vasculopathies
VII - Mediastinal involvement
VIII - Central-large-upper airway (incl pharyngeal-nasal) involvement
IX - Neuromuscular / CNS involvement - Disordered breathing during sleep
X - Systemic/Distant conditions, syndromes and reactions
XI - Miscellaneous
XII - Cardiovascular involvement / toxicity
XV - Pathology
XVII - Infections & related conditions